Article
Beyond Mutation Count: Trinucleotide Spectrum Quality Stratifies Microsatellite-Stable Cancers Across Three Tumor Types
2026-07-30
Abstract excerpt
Microsatellite-stable (MSS) cancers comprise ~70% of patients but lack biomarkers to guide prognosis or therapy. Current metrics—TMB, CNV, and MSI—measure genomic instability quantity but discard sequence-context information encoding repair pathway activity. We developed the Trinucleotide Mutation Spectrum (TMS), a metric of mutation spectrum quality based on the proportional distribution of mutations across 192 t...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 32e3dcac-d2d4-5183-aeca-022da948237e
- DOI
- 10.20944/preprints202607.2203.v1
